Flagship Harbor Advisors’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $356K | Hold |
|
|||||
|
2025
Q2 | $327K | Hold |
|
|||||
|
2025
Q1 | $324K | Hold |
|
|||||
|
2024
Q4 | $339K | Sell |
|
|||||
|
2024
Q3 | $568K | Buy |
|
|||||
|
2024
Q1 | $527K | Hold |
|
|||||
|
2023
Q4 | $536K | Sell |
|
|||||
|
2023
Q3 | $470K | Sell |
|
|||||
|
2023
Q2 | $508K | Sell |
|
|||||
|
2023
Q1 | $525K | Sell |
|
|||||
|
2022
Q4 | $549K | Hold |
|
|||||
|
2022
Q3 | $509K | Sell |
|
|||||
|
2022
Q2 | $560K | Sell |
|
|||||
|
2022
Q1 | $655K | Sell |
|
|||||
|
2021
Q4 | $867K | Buy |
|
|||||
|
2021
Q3 | $918K | Hold |
|
|||||
|
2021
Q2 | $918K | Sell |
|
|||||
|
2021
Q1 | $890K | Buy |
|
|||||
|
2020
Q4 | $810K | Sell |
|
|||||
|
2020
Q3 | $658K | Buy |
|
|||||
|
2020
Q2 | $538K | Buy |
|
|||||
|
2020
Q1 | $379K | Hold |
|
|||||
|
2019
Q4 | $455K | Hold |
|
|||||
|
2019
Q3 | $385K | Hold |
|
|||||
|
2019
Q2 | $435K | Hold |
|
|||||
|
2019
Q1 | $449K | Hold |
|
|||||
|
2018
Q4 | $383K | Hold |
|
|||||
|
2018
Q3 | $478K | Hold |
|
|||||
|
2018
Q2 | $445K | Hold |
|
|||||
|
2018
Q1 | $383K | Hold |
|
|||||
|
2017
Q4 | $393K | Hold |
|
|||||
|
2017
Q3 | $408K | Hold |
|
|||||
|
2017
Q2 | $373K | Hold |
|
|||||
|
2017
Q1 | $335K | Hold |
|
|||||
|
2016
Q4 | $324K | Buy |
|